Teva sues CMS over Medicare drug price negotiations
Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked ...
Teva Challenges Drug Price Law's Impact On Innovation, Generics
Teva Pharmaceuticals challenges the Inflation Reduction Act, arguing CMS's drug pricing policies harm generics, biosimilars, ...
Biden Administration Announces 15 More Drugs For Price Talks
US President Joe Biden's administration on Friday announced a new list of 15 drugs for which it will negotiate lower prices with pharmaceutical companies.
Ozempic, Wegovy among drugs subject to Medicare price controls
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...
Why were homeopathic practitioners in Maharashtra allowed to prescribe allopathic medication?
Maharashtra FDA allows homeopaths with pharmacology certificate to prescribe allopathic meds, sparking debate on healthcare ...
Fierce Healthcare3d
CMS faces renewed legal pressure on drug price negotiation program
Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price ...
Teva Hits Biden With New Challenge to Medicare Drug Price Talks
Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...
pharmaphorum4d
Obesity needs a new definition, says global commission
That is the conclusion of a report by the global Commission on Clinical Obesity – published in The Lancet Diabetes and ...
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...